Related Experiment Videos
Immunoglobulin variable-region structures in immunity and autoimmunity to DNA
T N Marion1, D M Tillman, M K Krishnan
1Department of Microbiology and Immunology, University of Tennessee, Memphis 38018.
The Tohoku Journal of Experimental Medicine
|May 1, 1994
Summary
Autoimmunity to DNA in systemic lupus erythematosus (SLE) arises from specific B cell responses, not random activation. Immune responses to DNA-containing antigens may drive SLE pathogenesis.
Area of Science:
- Immunology
- Autoimmunity
- Molecular Biology
Background:
- Autoantibodies to DNA are central to systemic lupus erythematosus (SLE) immunopathology.
- Understanding the origin of anti-DNA autoantibodies is key to elucidating SLE's immunological basis.
- Distinguishing between clonally-selective and polyclonal B cell activation is crucial.
Purpose of the Study:
- To investigate the B cell stimulation mechanisms underlying anti-DNA autoantibody production in lupus.
- To determine if anti-DNA autoantibodies result from specific antigen recognition or generalized B cell activation.
- To explore the potential role of DNA-containing antigens in initiating autoimmune responses.
Main Methods:
- Structural analysis of immunoglobulin variable regions from IgM and IgG anti-DNA antibodies in lupus-prone mice.
- Comparison of antibody structures from early (IgM) and late (IgG) stages of autoimmunity.
- Immunization of normal mice with peptide-DNA complexes to assess immune response characteristics.
Main Results:
- Structural analyses indicate that both IgM and IgG anti-DNA autoantibodies are generated by clonally-selective B cell stimulation.
- IgG anti-DNA autoantibodies are structurally similar to earlier IgM antibodies, sometimes originating from the same B cell clones.
- Peptide-DNA complex immunization in normal mice produced anti-DNA antibodies mirroring autoimmune antibodies.
- Immunized normal mice developed pathology resembling lupus nephritis.
Conclusions:
- Autoimmunity to DNA in SLE likely results from a specific immune response to DNA-containing antigens.
- The findings support a model where B cell stimulation is antigen-specific, targeting DNA or DNA complexes.
- This specific immune response may be the driving force behind SLE pathogenesis.